Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Remdesivir for Long COVID feasibility and safety study
ISRCTN72940450Phase 4Completed
- Sponsor
- University of Derby
- Start
- Oct 2024
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
01
Overview
Phase 4, open-label, single-arm trial of remdesivir in post-COVID syndrome, sponsored by University of Derby. Primary endpoints: Screening rates, Recruitment rate and 5 more. Started Oct 2024; status: completed.
02
Drugs
remdesivir
03
Conditions
post-COVID syndrome
Beyond the preview
Go deeper on ISRCTN72940450.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN72940450.